Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-166-9 | CAS number: 79-00-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
Carcinogenicity study of this chemical by gavage showed hepatocellular carcinomas and pheochromocytomas in mice but no carcinogenicity in rats (NCI, 1978).
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- 150 mg/kg bw/day
- Study duration:
- chronic
- Species:
- mouse
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Under the previous DSD Regulation, the EC authorities have classified the substance as Carcinogenic 3 ("Substances which cause concern for humans owing to possible carcinogenic effects but in respect of which the available information is not adequate for making a satisfactory assessment. There is some evidence from appropriate animal studies, but this is insufficient to place the substance in Category 2."), XnR40, according to the following rationale:
Under CLP regulation, this corresponds to carc. cat.2 H351.
- The findings of pheochromocytoma in the adrenal glands of the mouse (significantly increased for female animals in the highest dose group.).
- The (non-significant) occurrence of tumors in treated but not in untreated Osborne-Mendel rats.
- The significantly increased occurrence of liver foci in the initiation/promotion short term test with Osborne-Mendel rats (unclear significance).
- Also to be considered is the significantly increased incidence of sarcoma of varying location in the highest dose group of male rats compared with untreated animals, although a significant increase relative to vehicle control and to historical controls was not obtained.
- The data on genotoxicity is not consistent, but although a genotoxic mechanism cannot be unambiguously confirmed, it cannot be excluded.
In an assessment by USEPA, this chemical is classified to group C, a possible human carcinogen and is indicated to structurally related to 1,2-dichloroethane, a probable human carcinogen. On the other hand, International Agency for Research on Cancer (IARC) had evaluated in 1991 that 1,1,2 -trichloroethane was not classifiable as its carcinogenicity to humans (Group 3) because of limited evidence for the carcinogenicity in experimental animals and no available data in humans.
Additional information
A carcinogenicity study with 1,1,2-trichloroethane given by gavage from 150 mg/kg bw/d for 8 weeks, and then 200 mg/kg bw/d for 70 weeks showed hepatocellular carcinomas and pheochromocytomas in mice (50 per dose group). Nevertheless, the chemical was not carcinogenic in rats (50 per dose group) when given by gavage 70 mg/kg bw/d for 20 weeks and then 100 mg/kg bw/d for 58 weeks (NCI, 1978).
After subcutaneous administration of 15.37 or 46.77 mmol/animal (9.11 or 27.73 mg/kg body weight) to 50 male and 50 female Sprague-Dawley rats once a week for 2 years, there was a significant increase in the sarcoma incidence at various locations in the male rats of the highest dose group compared to untreated animals. However, these effects were not significantly increased relative to vehicle control (DMSO) and historical control values (Norpoth et al, 1988).
Further possible indications of a carcinogenic activity were also reported (Story et al., 1986). They were able to establish in this species the formation of liver foci in hepatocytes (GGT* foci assay). On the basis of the characteristics of these foci (Type II, according to the view of the authors at the time of the investigation presumably not preneoplastic), the significance for hepatocarcinogenicity and a promoting effect of 1,1,2 -trichloroethane cannot be conclusively established.
Carcinogenicity: via oral route (target organ): digestive: liver; glandular: adrenal gland
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.